Free Trial
→ June 12: $100 Turns Into $100,000? (From Brownstone Research) (Ad)tc pixel
LON:TSTL

Tristel Interim Earnings Report

Tristel logo
GBX 370.50 -9.50 (-2.50%)
As of 12:18 PM Eastern
ProfileEarnings HistoryForecast

Tristel EPS Results

Actual EPS
GBX 9.36
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Tristel Revenue Results

Actual Revenue
N/A
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Tristel Announcement Details

Quarter
Interim
Date
3/2/2026
Time
Before Market Opens
Conference Call Date
N/A
Conference Call Time
N/A

Conference Call Resources

Tristel Earnings Headlines

Tristel (LON:TSTL) Stock Passes Below 200-Day Moving Average - Should You Sell?
May 28, 2026  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=30805569
Tristel to Outline Strategy at ShareSoc Growth Event in Leeds
May 14, 2026  |  theglobeandmail.comhttps://www.theglobeandmail.com/investing/markets/stocks/TSNLF/pressreleases/834952/tristel-to-outline-strategy-at-sharesoc-growth-event-in-leeds/
In 30 days, you'll wish you'd read this email
A small power equipment company with $1.5 billion in orders is flying under the radar - but not for long. When the SpaceX and xAI S-1 filing hits the SEC in June, analysts will comb through supplier disclosures and this company's name is expected to surface. Dylan Jovine has identified the ticker and laid out the full investment thesis. The stock is still quiet - but that window may be closing fast.tc pixel
June 4 at 1:00 AM  |  Behind the Markets (Ad)
Audited Preliminary Results
April 21, 2026  |  lse.co.ukhttps://www.lse.co.uk/rns/audited-preliminary-results-8gy4vsf23e2zxef.html
Artemis Takes 3% Stake in Infection Prevention Group Tristel
April 20, 2026  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/artemis-takes-3-stake-in-infection-prevention-group-tristel?utm_source=marketbeat.com&utm_medium=referral
Tristel Director’s Associate Increases Stake in Infection Prevention Specialist
March 3, 2026  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/tristel-directors-associate-increases-stake-in-infection-prevention-specialist?utm_source=marketbeat.com&utm_medium=referral
See More Tristel Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Tristel? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Tristel and other key companies, straight to your email.

About Tristel

Tristel (LON:TSTL) is a global infection prevention company focussed on the manufacture and supply of products using its unique proprietary chlorine dioxide (ClO2) chemistry. The Company is a market leader in manual decontamination of medical devices, supplying hospitals under the Tristel brand, and under the Cache brand provides products for sporicidal surface disinfection, in a format which is a sustainable alternative to commonly used pre-wetted plastic wipes. Tristel's head office and manufacturing facility is located in Snailwell, near Cambridge, and operates globally employing approximately 250 people across 14 subsidiaries selling into 40 countries. The Company has been listed on the London Stock Exchange's AIM market since 2005 (AIM: TSTL). For more information about Tristel's product range please visit: https://tristel.com

View Tristel Profile
Earnings Tools